Vimpat Drug Indications

Links shared publicly online about this topic

Alkermes Presents Promising Preclinical Data On ALKS 33 For Multiple Disease Indications At Annual Meeting Of The Society For Neuroscience

medicalnewstoday.com — “Alkermes, Inc. (NASDAQ: ALKS) today announced the presentation of promising preclinical results for its proprietary opioid modulator, ALKS 33, showing the drug candidate's potential in multiple diView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 19, 2010 at 8:05 pm By:

mnt_weightloss MNT Weight Loss News Health News

Alkermes Presents Promising Preclinical Data On ALKS 33 For Multiple Disease Indications At Annual Meeting Of The Soci... http://mnt.to/3MTk

3 years ago...

Study indicates the amounts paid by antipsychotic manufacturers to D.C. Medicaid psychiatrists

news-medical.net — “The D.C. Department of Health (DOH) has released a study by George Washington University School of Public Health & Health Services (SPHHS) indicating the high levels of marketing by antipsychotic drug manufacturers to Medicaid psychiatrists in the District of Columbia.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 27, 2012 at 9:48 pm By:

Diabetes_Med News-Medical.Net Health News

Diabetes News: Study indicates the amounts paid by antipsychotic manufacturers to D.C. Medicaid psychiatrists: T... http://t.co/h7NVjxID

9 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390